Ticlopidine, Platelets and Vascular Disease

Nonfiction, Health & Well Being, Medical, Medical Science, Pharmacology, Specialties, Internal Medicine, Cardiology
Cover of the book Ticlopidine, Platelets and Vascular Disease by , Springer New York
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9781461383062
Publisher: Springer New York Publication: December 6, 2012
Imprint: Springer Language: English
Author:
ISBN: 9781461383062
Publisher: Springer New York
Publication: December 6, 2012
Imprint: Springer
Language: English

Blood platelets lack a nucleus. As a result their life span is short and they cannot reproduce themselves. Platelets share these qualities with the red blood cell. Plate­ lets and red blood cells, nevertheless, serve vital roles in the body. One major function of the platelet is its capacity to aggregate and thereby initiate intravas­ cular coagulation which often underlies such major diseases as myocardial infarc­ tion, cerebral infarction, and pulmonary embolism. For this reason in recent years, medical attention has been directed to drugs that inhibit platelet aggregation. Aspirin was the first drug to be proven effective in this area. Since then other drugs that share aspirin's fundamental biochemical action, inhibition of platelet cyclooxygenase, have also been studied. Very recently, ticlopidine, the first of what promises to be a new class of drugs inhibiting platelet aggregation and coagulation via an entirely different biochemical mechanism, has been exten­ sively studied and clinically shown to be as effective or more effective than aspirin in the prevention of ischemic cardiovascular and cerebrovascular disease.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Blood platelets lack a nucleus. As a result their life span is short and they cannot reproduce themselves. Platelets share these qualities with the red blood cell. Plate­ lets and red blood cells, nevertheless, serve vital roles in the body. One major function of the platelet is its capacity to aggregate and thereby initiate intravas­ cular coagulation which often underlies such major diseases as myocardial infarc­ tion, cerebral infarction, and pulmonary embolism. For this reason in recent years, medical attention has been directed to drugs that inhibit platelet aggregation. Aspirin was the first drug to be proven effective in this area. Since then other drugs that share aspirin's fundamental biochemical action, inhibition of platelet cyclooxygenase, have also been studied. Very recently, ticlopidine, the first of what promises to be a new class of drugs inhibiting platelet aggregation and coagulation via an entirely different biochemical mechanism, has been exten­ sively studied and clinically shown to be as effective or more effective than aspirin in the prevention of ischemic cardiovascular and cerebrovascular disease.

More books from Springer New York

Cover of the book Anal and Rectal Diseases by
Cover of the book Uranus, Neptune, and Pluto and How to Observe Them by
Cover of the book Integrated Frequency Synthesis for Convergent Wireless Solutions by
Cover of the book Attitudinal Judgment by
Cover of the book Measuring Globalisation by
Cover of the book ADHD as a Model of Brain-Behavior Relationships by
Cover of the book Behavioural Oncology by
Cover of the book Packaging of High Power Semiconductor Lasers by
Cover of the book Kidney Development in Renal Pathology by
Cover of the book Who Cares About Wildlife? by
Cover of the book The Craft of Scientific Writing by
Cover of the book Handbook of Musculoskeletal Pain and Disability Disorders in the Workplace by
Cover of the book Biochemistry by
Cover of the book Advances in HIV-1 Assembly and Release by
Cover of the book Robotic Surgery of the Head and Neck by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy